View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

IDE at DDRS 2020 on 17-19 March

We are happy to announce that IDE will have a place to exhibit in the upcoming DDRS meeting.

Come and visit us in our stand at “International Conference On Advances In Pharmaceutical Drug Development, Quality Control And Regulatory Sciences” in Margaret Island, Budapest, Hungary.

International Conference On Advances In Pharmaceutical Drug Development, Quality Control And Regulatory Sciences (DDRS 2020) will be organised on 17-19 March 2020.

The conference will address new trends in pharmaceutical, regulatory science of biological and non-biological complex drugs (NBCDs) and the challenges for their correct use. The conference will also discuss advances in bioanalytical methodologies to characterize these complex drugs with their critical quality attributes and Drug-Device Combination products. Topics will be addressed regarding the bioequivalence evaluation of complex drugs.

The conference will update on regulatory harmonization attempts for the bioequivalence of complex drugs with an insight into drug dissolution/drug release, nanomedicines, biodegradable polymers and bioanalytics as a sensitive and specific state of the art assessment method today.

Our general manager Prof Dr Atilla HINCAL, our regulatory affairs manager Med Bio MSc A Pelin YARGAN and our clinical trials manager Pharm, B Sc Cemre OZSEVEN will participate in the conference on behalf of IDE.

Please feel free to ask for an appointment with your questions by filling out the enquiry form attached to this page.

İDE® was established in 1998 as a “Contract Research Organisation” providing integrated services.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology